EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0810
+0.0002 (0.25%)
At close: Dec 3, 2025
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $828.26 thousand as of December 4, 2025. Its market cap has decreased by -93.84% in one year.
Market Cap
828.26K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 828.26K, a decrease of -98.82%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 826.21K | -15.39% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | 68.63M | 4,887.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 819.20M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 520.12M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.91M |